Experience

Aviwell

• France
• Biotechnology
• 1 - 100 Employee

• CTO / Directeur de la Technologie

  • Nov 2021 - Present

• Scientific Officer / Responsable Scientifique

  • Oct 2019 - Nov 2021



Microbes Only

• Toulouse Area, France

• Founder and Principal Consultant

  • Sep 2017 - Sep 2020

  Consultation services for microbiology and microbiome projects from inception through patenting, publishing, and production. Consultation services for microbiology and microbiome projects from inception through patenting, publishing, and production.



INSERM

• France
• Research Services
• 700 & Above Employee

• Research Scientist, Institute of Cardiovascular and Metabolic Diseases

  • Feb 2015 - Mar 2017

  The research focus of the Funtional Genomics of Metabolic Diseases group is to decipher the molecular and microbial mechanisms impacting diabetes, dyslipidemia and obesity as well as their co-morbidities such as heart failure and liver fibrosis. The research focus of the Funtional Genomics of Metabolic Diseases group is to decipher the molecular and microbial mechanisms impacting diabetes, dyslipidemia and obesity as well as their co-morbidities such as heart failure and liver fibrosis.



Vaiomer

• France
• Biotechnology
• 1 - 100 Employee

• Senior Scientist & Research Project Manager

  • Feb 2015 - Sep 2016

  Vaiomer focuses on the molecular interaction between the microbiome and host cells as applied to the discovery and development of novel biomarkers and therapeutic targets for metabolic diseases. Vaiomer focuses on the molecular interaction between the microbiome and host cells as applied to the discovery and development of novel biomarkers and therapeutic targets for metabolic diseases.



Chr. Hansen

• Denmark
• Biotechnology Research
• 700 & Above Employee

• Senior Research Scientist, Health & Nutrition Division

  • May 2010 - Oct 2014

  Discovery team responsible for the screening and research of current and next generation probiotics, the development of technical in vitro and in vivo platforms for biomarker identification, and building a strong portfolio of scientific data to support our commercial probiotic business. Discovery team responsible for the screening and research of current and next generation probiotics, the development of technical in vitro and in vivo platforms for biomarker identification, and building a strong portfolio of scientific data to support our commercial probiotic business.



Washington State University

• United States
• Higher Education
• 700 & Above Employee

• Senior Postdoctoral Research Scientist, Molecular Biosciences

  • Jul 2004 - Jan 2010

  • Identification and characterization of proteins exported by the Campylobacter jejuni flagellar type III secretion system using a novel heterologous genetic screen and investigation of the role of these proteins in pathogenesis by C. jejuni. • Investigation of the C. jejuni CadF adhesin and expression of its binding epitope in S-layer fusions of Caulobacter crescentus and Lactobacillus helveticus, regulation of C. jejuni flagellar filament expression, and competitive colonization studies in avian hosts. Show less



UCHealth

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Postdoctoral Research Scientist, Medical Microbiology

  • Mar 2003 - Mar 2004

  • Investigated regulation of pyoverdine (PVD) biosynthesis and ToxA production in Pseudomonas aeruginosa from mutants in a pvdS regulated gene cluster. • Performed large scale purifications of the three major PVD types for physiological and regulatory characterization in cross-feeding experiments. • Investigated regulation of pyoverdine (PVD) biosynthesis and ToxA production in Pseudomonas aeruginosa from mutants in a pvdS regulated gene cluster. • Performed large scale purifications of the three major PVD types for physiological and regulatory characterization in cross-feeding experiments.



Marshfield Clinic Health System

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Postdoctoral Research Scientist, Clinical Research

  • Nov 2000 - Feb 2003

  • Developed procedures and database for rapid molecular identification of organisms involved in bacteremia by terminal restriction fragment length polymorphisms (T-RFLP) profiles. • Developed PCR protocols and coculture technique for implementation in screening potential infectious agents involved in pediatric Inflammatory Bowel Disease from intestinal biopsies. • Developed procedures and database for rapid molecular identification of organisms involved in bacteremia by terminal restriction fragment length polymorphisms (T-RFLP) profiles. • Developed PCR protocols and coculture technique for implementation in screening potential infectious agents involved in pediatric Inflammatory Bowel Disease from intestinal biopsies.